In the present study, we have investigated the level and frequency of expression of ERβ in ER-negative tumours and its association with the basal phenotype and other established markers of prognosis, such as indicators of signal transduction pathways, proliferative and apoptotic markers. The gene discussed is ESR2; the disease is neoplasm.